Scribd
Upload
25 views

8th Slide

mm

Uploaded by

Marsella Lulu Aulia
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
25 views

8th Slide

mm

Uploaded by

Marsella Lulu Aulia
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 4

8th slide

“Vaccine equity is the challenge of our time, And we are failing.”


If we really think about that, That is a strong words from
Tedros Adhanom Ghebreyesus, Director-General of the (WHO), told In the meeting of economic and
social council at april 26 2021

With the number of new COVID-19 cases around the world highly increasing over for the past
months, as we can say since the second quartal of the 2021
We can say the case of COVID 19 infection approaching the highest infection rate observed during
the pandemic

Its also happening because of..


The rapid spreading variants,
the inconsistent application and premature easing of public health measures
fatigue with social restrictions (as we all experience since PPKM Java-Bali has been admitted by the
goverment) and
the dramatic inequity in vaccine coverage have all led to an alarming spike in new cases and deaths.

the unequal distribution of vaccines is not only a moral outrage, but economically and
epidemiologically self-defeating

9th Slide

learning from the mistakes of 40 years ago, that the world made
when there is a HIV/AIDS crisis
and it was due to the slow to deploy life-saving antiretroviral drugs to poor countries

We as learning creatures and we are at least trying progress to be better

Trying to do what we can to prevent such a devastating condition repeated by,


COVAX has distributed millions doses to 100 countries, but...... the problem is:
its nowhere near enough, 

as we can see from the graphics


out of the 832 (8 hundred and 32) million vaccine doses administered
82 percent have gone to high- or upper-middle-income countries,
while only 0.2 percent have been sent to the low-income counterparts.

Its sad to see such an imbalance by seeing at the number diffrence.. its huge.

Now we see...
In high-income countries alone, 1 in 4 people have been vaccinated,
And again...
the ratio drops precipitously (pre-si-pi-syesli) to 1 in 500 in poorer countries.
Noting that vaccine inequality translates into social and economic inequality, any delay in response
to the current crisis equates to more loss of life and increased poverty.  So, a global plan is needed to
effectively address this issue
The right to health is a universal human right, emphasizing that it that should not be up for sale or
denied due to profit concerns.

How?
COVAX Facility has delivered 40 million doses to 114 economies — working with Pfizer,
AstraZeneca and the Serum Institute in particular —
and raised $8.3 billion towards the Advance Market Commitment. 

The Facility will be able cover 2 to 3 per cent of the global population by the end of summer,
However, there are:
supply constraints,
intense competition for doses and
problems with restrictions on vaccine exports

Describing the global focus on equitable allocation as a success in itself, it with the scepticism of the
message “no one is safe until everyone is safe”, a year earlier. 

Observing that the emergence of variants has changed minds, it has also led to vaccine panic,
with countries buying doses from everywhere,
including through bilateral agreements, which are inefficient and “not in anybody’s self-interest”.  
Governments should instead remove export and import control measures that slow the delivery of
vaccines and supplies. 

Nor is vaccine diplomacy a health-based approach to sharing, emphasizing that vaccines should be
delivered through a multilateral mechanism, such as COVAX. 

Equitable allocation would add $9 trillion to the global economy, he noted, warning that, without it,
“we’re all going to pay the price”.

role that the private sector can play in scaling up vaccine production and promoting equitable
distribution, said that sector has a responsibility — rather than a role to play — to build national
capacities for vaccine manufacturing so that Governments can address problems on the local level. 

about potential challenges faced by developing countries, even if granted licensing and
manufacturing rights, the biggest such challenge is one of funding. 

The private sector must create a new business model that allows for profitable universal vaccine
production, potentially by allowing countries to earn the right — through the licensing of intellectual
property — to manufacture their own vaccines and profit from doing so, he said.
Although the cost of implementation is miniscule compared to the damage already suffered, human
nature would rather spend money on treatment than on prevention. Daripada work on;

Calling for the scaling up of education systems,

the world needs trained operators who, bolstered by the global transfer of technology and skills, can
develop the next generation of vaccines for the crises to come.

outlining how the global trading system can minimize intellectual property rights barriers, said a
transparent and predictable framework is needed to curtail vaccine nationalism, whose proponents
call for irregular trade measures, such as banning vaccines outright.  The impact of such measures
disproportionately harms low-income countries, she pointed out.

Emphasizing that economic recovery depends on vaccinating large swathes of a country’s


population, she cautioned that vaccine nationalism could cost the global economy $1.2 trillion a
year.  WTO, for its part, provides members with a legal framework within which to discuss
flexibilities in relation to trade agreements.
 Noting that members are currently discussing waivers to the trade-related intellectual property rights
agreement, she said “the question to ask is not if or how, but when the [trade-related intellectual
property rights] waiver will be achieved.”  The waiver is in full compliance with the 2030 Agenda,
clearly outlined in Sustainable Development Goal 3, target 3.b, she pointed out, describing waivers
as the first step towards realizing a vaccine for all. 
From a finance perspective, she said, they boost incentives for private and public investment in
infrastructure and productive capacity.  She went on to call for global and regional actions to tackle
major bottlenecks faced by developing countries, including their lack of technology and capital, low
capacity to uphold standards, weak institutional frameworks, small market size and poor
infrastructure.

agreeing that global vaccine production and supply is struggling to meet global demand,
and that the scarcity of tools and vaccines has reinforced disparities, said countries with productive
capacity benefit from privileged access.  That must prompt the international community to rethink
the global agenda, moving away from the focus on economic efficiency to enabling local capacity in
low- and middle-income countries,

To do so, vaccine developers must share their intellectual property and transfer their know-how,
giving countries the opportunity to leverage the emergence of mRNA vaccines, which require less
capital investment, he added, emphasizing that mechanisms for enabling technology transfer must be
transparent and open to multiple manufacturers.  He also called for reducing barriers to increasing
production, saying that countries must have new options for surmounting obstacles.  “The bottom
line is that we need to truly treat vaccines as a global public good in themselves,”

So much going on in the world


And also in my mind

Political reason
Indonesia keep buying
But the vaccine nusantara is banned

You might also like